Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joerg Herrmann

Showing results (251-260 of 269) with videos related to

Pageof 27
Sort By:
JACC. Cardiooncology|January 13, 2025
SGLT2i and Primary Prevention of Cancer Therapy-Related Cardiac Dysfunction in Patients With DiabetesAmmar W Bhatti, Rushin Patel, Sourbha S Dani, et al.
JAMA Oncology|November 13, 2025
Immune Checkpoint Inhibitor-Associated Cardiovascular Toxic Effects: International Cardio-Oncology Society Position StatementJoerg Herrmann, Ana Barac, Joseph Carver, et al.
Blood Cancer Journal|August 12, 2024
Chimeric antigen receptor T-cell therapy associated hemophagocytic lymphohistiocytosis syndrome: clinical presentation, outcomes, and managementArushi Khurana, Allison C Rosenthal, Razan Mohty, et al.
Frontiers in Cardiovascular Medicine|November 25, 2022
Radiation therapy induces immunosenescence mediated by p90RSKMasaki Imanishi, Haizi Cheng, Sivareddy Kotla, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2022
Pembrolizumab in Combination with Neoadjuvant Chemoradiotherapy for Patients with Resectable Adenocarcinoma of the Gastroesophageal JunctionMojun Zhu, Chunhua Chen, Nathan R Foster, et al.
JACC. Cardiooncology|February 19, 2025
Cardiovascular Safety in Oncology Clinical Trials: JACC: CardioOncology PrimerMarc P Bonaca, Ninian N Lang, Alice Chen, et al.
Antioxidants (Basel, Switzerland)|December 30, 2025
SHP2: A Redox-Sensitive Regulator Linking Immune Checkpoint Inhibitor Therapy to Cancer Treatment and Vascular RiskSilvia Fernanda López Moreno, Stefania Assunto Lenz, Bernardo Casso-Chapa, et al.
Cardio-Oncology (London, England)|December 9, 2020
Perspectives on the COVID-19 pandemic impact on cardio-oncology: results from the COVID-19 International Collaborative Network surveyDiego Sadler, Jeanne M DeCara, Joerg Herrmann, et al.
European Heart Journal|August 26, 2022
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)Alexander R Lyon, Teresa López-Fernández, Liam S Couch, et al.
European Heart Journal. Cardiovascular Imaging|August 26, 2022
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)Alexander R Lyon, Teresa López-Fernández, Liam S Couch, et al.
Pageof 27

Showing results (251-260 of 269) with videos related to

Sort By:
Pageof 27
JACC. Cardiooncology|January 13, 2025
SGLT2i and Primary Prevention of Cancer Therapy-Related Cardiac Dysfunction in Patients With DiabetesAmmar W Bhatti, Rushin Patel, Sourbha S Dani, et al.
JAMA Oncology|November 13, 2025
Immune Checkpoint Inhibitor-Associated Cardiovascular Toxic Effects: International Cardio-Oncology Society Position StatementJoerg Herrmann, Ana Barac, Joseph Carver, et al.
Blood Cancer Journal|August 12, 2024
Chimeric antigen receptor T-cell therapy associated hemophagocytic lymphohistiocytosis syndrome: clinical presentation, outcomes, and managementArushi Khurana, Allison C Rosenthal, Razan Mohty, et al.
Frontiers in Cardiovascular Medicine|November 25, 2022
Radiation therapy induces immunosenescence mediated by p90RSKMasaki Imanishi, Haizi Cheng, Sivareddy Kotla, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2022
Pembrolizumab in Combination with Neoadjuvant Chemoradiotherapy for Patients with Resectable Adenocarcinoma of the Gastroesophageal JunctionMojun Zhu, Chunhua Chen, Nathan R Foster, et al.
JACC. Cardiooncology|February 19, 2025
Cardiovascular Safety in Oncology Clinical Trials: JACC: CardioOncology PrimerMarc P Bonaca, Ninian N Lang, Alice Chen, et al.
Antioxidants (Basel, Switzerland)|December 30, 2025
SHP2: A Redox-Sensitive Regulator Linking Immune Checkpoint Inhibitor Therapy to Cancer Treatment and Vascular RiskSilvia Fernanda López Moreno, Stefania Assunto Lenz, Bernardo Casso-Chapa, et al.
Cardio-Oncology (London, England)|December 9, 2020
Perspectives on the COVID-19 pandemic impact on cardio-oncology: results from the COVID-19 International Collaborative Network surveyDiego Sadler, Jeanne M DeCara, Joerg Herrmann, et al.
European Heart Journal|August 26, 2022
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)Alexander R Lyon, Teresa López-Fernández, Liam S Couch, et al.
European Heart Journal. Cardiovascular Imaging|August 26, 2022
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)Alexander R Lyon, Teresa López-Fernández, Liam S Couch, et al.
Pageof 27